SCHEMBL12366281

SCHEMBL12366281

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2ccccc2C(F)(F)F)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.40
C5AR1 P21730 6/20 0.37
TDP1 Q9NUW8 3/20 0.37
ALDH1A1 P00352 3/20 0.37
GAA P10253 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RXRA P19793 2/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
NPSR1 Q6W5P4 3/20 0.36
KDM4E B2RXH2 3/20 0.35
ATM Q13315 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PARG Q86W56 2/20 0.35
GNRHR P30968 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366246 0.93 GAA (0.39) MDM2C5AR1TDP1ALDH1A1GAA
SCHEMBL12366328 0.92 NR1H2 (0.41) MDM2ALDH1A1RXRANR1H2NR1H3
SCHEMBL12366339 0.91 ALDH1A1 (0.42) ALDH1A1CYP3A4CYP2C9CYP2C19RXRA
SCHEMBL12366467 0.91 RXRA (0.37) MDM2C5AR1CYP3A4CYP2C9CYP2C19
SCHEMBL12366504 0.90 MCL1 (0.37) MDM2ALDH1A1GAARXRANR1H2
SCHEMBL12366461 0.90 CMA1 (0.35) MDM2C5AR1GAACYP3A4CYP2C9
SCHEMBL12366272 0.89 RXRA (0.42) C5AR1TDP1ALDH1A1GAARXRA
SCHEMBL12366466 0.89 RXRA (0.38) MDM2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL12366463 0.89 RXRA (0.36) ALDH1A1CYP3A4CYP2C9CYP2C19RXRA
SCHEMBL12366323 0.89 NR1H2 (0.39) MDM2GAACYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed